Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus

Stock Information for Aratana Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Aratana Therapeutics Inc.

Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., Community Health Systems, Equity Bancshares, Inc., Ford Motor Company, Interface, Inc., Monotype Imaging Holdings, Inc., PetIQ, Inc., and Pinduoduo, Inc.
PETX, KEYW, and ZAYO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
Aratana Therapeutics Reports First Quarter 2019 Financial Results
Aratana Therapeutics to Present at Stifel 2019 Dental & Veterinary Conference
INVESTOR ALERT: Monteverde & Associates PC is Investigating the Announced Buyout
ARATANA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aratana Therapeutics - PETX
PETX, WP, and EFII SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
MERGER ALERT - PETX and SRMC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.